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The quinone chemistry that gives rise to the rather unusual strict bifurcation of electron transfer at the Qo site of the cytochrome bc
complexes remains controversial. In this article, I review recent ideas and propose a ‘‘logic-gated’’ binding mechanism that combines
classical quinone electrochemistry with specific hydrogen bonding requirements and results in a reversible reaction that minimizes unwanted
side-reactions that could otherwise undermine the efficiency of the Q-cycle proton/electron coupling mechanism.
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The cytochrome bc1 complexes are a superfamily of
membrane-embedded enzymes that occur widely in eukary-
otic and prokaryotic respiratory and photosynthetic electron
transfer chains. All share a common catalytic core of three
subunits, an iron sulfur protein (ISP), cytochrome c1, and
cytochrome b, containing a 2Fe–2S cluster, heme C, and
two hemes B, respectively. These catalyze its ubiquinol–
cytochrome c oxidoreductase and associated transmembrane
proton transfer activities. Structures of several eukaryotic bc
complexes and of the homologous cytochrome bf complex
from cyanobacteria and green algae have been solved at
atomic resolution [1–7]. It is widely agreed that the electron
and proton transfer pathway occurs by a ‘Q-cycle’ mecha-
nism [8] in which ubiquinol oxidation at the ubiquinol-
binding Qo site results in a bifurcated electron transfer
where one electron is transferred to the ISP and the second
to the lower potential heme bL. The electron on heme bL
moves perpendicular to the membrane plane within the
cytochrome b to reduce the higher potential heme bH, which0005-2728/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbabio.2004.04.021
Abbreviations: ISP, Rieske iron sulfur protein; Subscripts ox and red, the
oxidized and reduced states; SHE, standard hydrogen electrode; Em,
midpoint potential vs. the standard hydrogen electrode; FTIR spectroscopy,
Fourier transform infrared spectroscopy
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E-mail address: PRR@UCL.AC.UK (P.R. Rich).in turn reduces ubiquinone at a second ubiquinone binding
site, Qi.
Despite the wealth of structural, thermodynamic, and
kinetic information, some key details of the basic electron/
proton transfer mechanism have remained unclear. Particu-
larly enigmatic are the chemical and physical factors that
cause the rather unusual strict bifurcation of electron transfer
at the Qo site, and a range of models have been suggested
[9–17]. However, in an important recent article [18], it was
pointed out that none of these account for the known
reversibility of the reaction or the way in which unwanted
electron transfer short-circuit reactions are prevented. In this
article, I attempt to review recent ideas and propose a ‘logic-
gated’ binding mechanism that addresses these concerns and
which is based on classical quinone electrochemistry.2. Classical quinone electrochemistry
The complexities of the electron and proton transfer
reactions of para-quinone systems such as ubiquinone and
menaquinones are well described in terms of the ‘scheme of
squares’ in which the possible pathways of oxidation/
reduction are defined in terms of all possible microscopic
proton and electron transfer steps [19–21]. In aprotic media,
formation of the dianionic quinol is energetically costly in
comparison to the anionic semiquinone. As a result, the
electrochemistry is relatively simple, with two reversible
Fig. 2. pH dependencies of current peak positions of hydroquinone. The
voltammetry of Fig. 1 was repeated at various pH values. The voltages at
which the oxidative and reductive peak currents occurred are plotted as a
function of pH. At very high pH values, a second minor oxidative peak was
observed (depicted with a dashed line) that is interpreted as representing
oxidation via the quinol monoanion route of any residual quinol not already
oxidized via the dianionic quinol route.
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among other factors by the dielectric strength of the solvent.
However, in protic media, the strong affinity of the quinol
hydroxyls for protons results in a stable, neutral quinol at
pH values below their pKs that is greatly stabilized in
relation to semiquinone. This results in the potential of the
second reduction step (Q
S
to QH2) being much higher than
that of the first (Q to Q
S
), giving rise to the n = 2 behavior
of its equilibrium redox chemistry. However, this means that
the semiquinone intermediate is thermodynamically unsta-
ble, accounting for the very poor redox reactivity of free
solution quinone [22] and giving rise to electrochemistry in
protic media that can exhibit waves of reduction and
oxidation that are widely separated from each other, and
occurring at large overpotentials vs. the equilibrium n = 2
midpoint value. This behavior is illustrated in Fig. 1 for
unsubstituted para-benzoquinol in 1:1 v/v ethanol/water at
various pH values. Below pH 10, single, widely separated
oxidative and reductive waves are seen and only at very
high pH values do the oxidative and reductive waves
approach the approximately 30 mV separation dictated by
theory for an n= 2 transition. The current peak positions are
dependent on sweep rate and do not represent equilibrium
potentials. Nevertheless, information on mechanism may beFig. 1. Cyclic voltammetry of hydroquinone. para-Benzoquinol was
dissolved to 1 mM in 1:1 v/v ethanol/water containing 100 mM KCl and
with 10 mM succinate, 10 mM phosphate, 10 mM TRIS, and 10 mM
glycine as buffers. pH was adjusted with HCl or KOH and the sample at 23
jC was made anaerobic with oxygen-free nitrogen. Conventional three-
electrode cyclic voltammetry was performed with a 3-mm-diameter
polished glassy carbon working electrode, a platinum spade counter
electrode, and a silver/silver chloride reference. Voltage was scanned with a
triangular waveform at 20 mV s 1.deduced from their pH dependencies (Fig. 2). The reductive
wave becomes pH-independent at high pH where reaction
proceeds via the direct reduction of the unprotonated qui-
none. As the pH is lowered, however, the peak position
becomes pH-dependent as the reaction switches to a route
via the couple, QH+/QHS. In contrast, the oxidative wave
becomes pH-independent at low pH values, stabilizing at a
potential of + 820 mV, close to the potential of the couple
QH2/QH2
S +, and indicative of a direct one-electron oxida-
tion of QH2 as the rate-limiting process. As the pH is raised,
however, the rate becomes pH-dependent as the reaction
proceeds instead via oxidation of the anionic and dianionic
forms of the quinol. Hence, although the waves themselves
result in full n = 2 conversion between quinone and quinol
forms, this is because the reactions are kinetically limited by
the first, energetically unfavorable one-electron transfers,
after which the second, energetically favorable electron
transfer will occur very rapidly to produce overall an n = 2
redox change. This explanation of behavior in terms of n = 1
steps, rather than synchronous n= 2 electrochemistry, seems
fully consistent with a wide range of electrochemical data on
quinones.3. Existing models for bifurcation
In a simple model based on known quinone chemistry
and the lack of a detectable semiquinone intermediate, it
was proposed previously [11] that the bifurcation is
achieved by the fact that the forward rate constant, k1, for
the first electron transfer (see Fig. 3) of the active enzyme–
Fig. 3. Proposed reaction cycle of the Qo site in a ‘logic-gated’ fit mechanism. Starting with oxidized Qo site (intermediate A), formation of an active complex
involves binding of ubiquinol by initial hydrogen bonding to an H-bond acceptor (possibly residue E271 of cytochrome b that may be in its carboxylate form
when heme bL is oxidized), followed by rotation of the ISP and formation of a second H-bond (possibly the H161 ligand in its imidazolate form when ISP is
oxidized) to form active intermediate C. This is in rapid reversible equilibrium via the unstable semiquinone intermediate D with a form (intermediate E) with
both ISP and heme bL reduced, and with their H-bonding sites having become protonated and acting as H-bond donors to the carbonyls of bound ubiquinone.
The conversion of C to E is the same as the ‘three-rate-constant’ model for the forward bifurcation mechanism proposed in Ref. [11]. The forward reaction of
ubiquinol oxidation is completed by rotation of ISP toward cytochrome c1 and deprotonation of H161 (step E to F), ubiquinone dissociation (step F to G),
reoxidation of heme bL (by heme bH), and redox-linked deprotonation of E271 (step G to H) and electron donation to cytochrome c1 (step H to A). Although
shown as specific sequential processes for simplicity, the exact orders of the microscopic steps of substrate (un)docking and electron and proton transfers (i.e.,
steps E to B in clockwise direction and B to E in anticlockwise direction) may not be important and, indeed, their order is likely to depend on conditions such as
turnover rate, substrate supplies, and pH. Reversed electron transfer (which occurs rapidly at high values of protonmotive force in intact mitochondria) is an
exact reversal of the forward process. Catalytically active substrate is only possible in intermediates C, D, and E.
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constant, k 1, (an inevitable consequence of an unstable
semiquinone intermediate) and the forward rate constant, k2,
for the second electron transfer is of a sufficient magnitude
that it can compete with k 1 to provide the net observed
forward reaction rate. This simple combination of relative
rate constants means that the second electron transfer
‘drives’ the first and leads to an ‘all-or-nothing’ reaction
in which both electrons or neither are transferred, hence
producing the required obligatory bifurcation.
However, a number of other viable models have also
been suggested and several other developments have
prompted questions as to whether the mechanism may
involve rather more complicated factors. For example, the
structural data have revealed a remarkable long-range rota-
tion of the globular protein domain of the ISP center
between a conformation that can dock with the incoming
ubiquinol and one that can donate an electron to the heme C
of cytochrome c1 [1–4]. This has prompted models in which
such movement, possibly concerted with other steps in the
catalysis, is an essential part of the mechanism for bifurcated
electron transfer [12,14,23]. On the basis of positions of
various bound inhibitors, the Qo site appears to be ratherextensive. Other data on the EPR line shape of the ISP has
indicated that two ubiquinones might be bound within the
Qo site [24], a suggestion supported by some inhibitor
binding titrations [25] and more recently by NMR monitor-
ing of ubiquinone displacement [26]. These observations
have led to proposals that two ubiquinols are required for
functioning of the Qo site [9] or that two sequential binding
positions for ubiquinone species might be operative [13].
Further observations have added another dimension of
complexity in terms of the possible functional significance
of the known dimeric structure of the enzyme. When the
first structures were solved, it became clear from interheme
B distances that electronic communication between the four
hemes B of a single dimer was likely to be rapid on the time
scale of turnover rate of the enzyme, because of the close
proximity of the two hemes bL [1–4]. This connectivity has
several implications for steady state behavior. For example,
it provides the most reasonable explanation for the peculiar
sigmoidal curves for inhibition by Qi inhibitors such as
antimycin A [27,28]. However, several recent studies have
highlighted the possibility that an even more intricate
interplay between monomeric units may exist. For example,
crystals of a yeast bc1-cytochrome c cocomplex revealed a
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ubiquinone bound preferentially in the Qi site of the same
monomer [29]. Inhibitor titer studies have suggested that
some Qo inhibitors can act fully at a titer of only one per
dimer [30–32] and recent kinetic work with yeast bc
complex has been interpreted in terms of anticooperative
interactions between monomers and long-range control of
Qo site function by heme bH and/or Qi redox state [28] (c.f.
Ref. [33]).
However, in a key development recently, Osyczka et al.
[18] have pointed out that none of these models address
adequately the fact that the reaction of the Qo site is rapidly
reversible (an inevitable feature since the reaction is known
to operate close to equilibrium in functioning mitochondria)
or the ways in which unwanted electron transfer side
reactions are controlled that would otherwise compromise
bifurcation and decrease the proton/electron coupling effi-
ciency. The fact that all prior models did not satisfy these
requirements led these authors to suggest a mechanism in
which the two electron transfers from ubiquinol occur
within the reorganization time of the participating mole-
cules, leading to a ‘true’ concerted two-electron process in
which a classical semiquinone intermediate does not even
occur.4. A ‘logic-gated’ mechanism for quinone chemistry
at Qo
There are a number of ways in which more conventional
models may also be developed to accommodate the con-
cerns in Ref. [18], although, admittedly, with an inevitable
further dimension of complexity. Several proposals have
appeared recently in which the issue of control of side
reactions has also been addressed in terms of physical
movement of semiquinone intermediate [13], formation of
heme bL donor of a quinol-ISP with delocalized electron
density [34], and a mechanism incorporating aspects of ISP
movement and long-range allosteric effects [35].
However, it is also possible to develop the ‘three-rate-
constant’ model of bifurcation control through an unstable
semiquinone intermediate [11] in a way that may provide a
particularly simple possible model for bifurcation, revers-
ibility, and control of unwanted short-circuit reactions, while
conforming to known classical quinone electrochemistry. In
such a model, both forward and reverse reactions are
proposed to proceed via the same unstable semiquinone
intermediate (intermediate D in Fig. 3), i.e., a rate constant
k 2, which is much smaller than k2, is added to the simple
kinetic model in Ref. [11], resulting in an obligatory ‘all-or-
nothing’ reverse reaction in the same way as the forward
reaction, in which obligatory ‘unification’ occurs to reduce
ubiquinone with one electron from heme bL and the second
from ISP. The weakness in such a scheme, following the
logic in Ref. [18], would be the inability to prevent a variety
of unwanted short-circuit reactions that would occur ifubiquinol or ubiquinone were to bind in a condition in
which only one electron were present on the ISP/heme bL
pair. The way in which this is overcome is proposed to lie in
the nature of enzyme–substrate complex that is active in
electron transfer. Specifically, to overcome the kinetic
barrier of the highly unfavorable first electron transfer, it
is proposed that two H-bonds in a correct orientation are
required to properly dock the substrate and to form the
reactive enzyme–substrate complex. In the case of ubiqui-
nol binding, these are provided by two H-bond acceptor
sites that bond to the two ring hydroxyl protons (interme-
diate C in Fig. 3). For ubiquinone binding, in contrast, two
H-bond donor sites are required for bonding to the two
quinone carbonyls (intermediate E). These interactions in
effect activate the quinol by providing the equivalent of
partial deprotonation and activate the quinone by providing
partial preprotonation, hence providing an accessible kinetic
pathway through the semiquinone intermediate in a manner
exactly equivalent to quinone electrochemistry in solution
with a series of n = 1 redox and protonation steps (Section 2
and Ref. [20]).
The overall result is that quinol can bind productively
only to ISPox/bLox (intermediate C) whereas ubiquinone can
bind productively only to ISPred/bLred (intermediate E). If
substrate binds with only one or no H-bonds to another
intermediate (A,B,F,G,H in Fig. 3), no reactions can occur
because the inevitable semiquinone product would be far
too unstable to provide a viable intermediate in the reaction
pathway. These H-bonding restrictions to formation of an
active enzyme–substrate complex, coupled with the ‘all-or-
nothing’ nature of the reaction mechanism, removes the
possibility of major short-circuiting slip reactions that
would otherwise invalidate the mechanism [18]. The mech-
anism, which is really a classical Koshland ‘induced-fit’
process [36], may be described as ‘logic-gated’ fit and
suggests a novel aspect of enzyme/substrate recognition
that may find a wider applicability in enzymology of
reversible reactions because, besides the specific outcome
for electron transfer enzymes of obviating unwanted side
reactions, it can also provide a means of minimizing
competitive product inhibition.5. Structural considerations
It has already been pointed out, on the basis of structural
models with a range of inhibitors bound in the Qo site [2,4],
that docking of ubiquinol most likely involves formation of
hydrogen bonds with H161 of the ISP and E271 (bovine
numbering) of the cytochrome b polypeptide. Combined
with the observations of the remarkable long-range move-
ment of the globular domain of the ISP, this has led to a
view of formation of an occluded enzyme–substrate com-
plex in which the ISP physically moves to hydrogen bond to
the cytochrome b-bound ubiquinol (step B to C in Fig. 3). In
the ‘logic-gated’ model proposed here, it is the hydrogen-
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docking ubiquinol to form intermediate C, both H-bonding
residues would have to be in proton-deficient forms. Hence,
if H161 and E271 are indeed the docking residues, H161
would have to be in its imidazolate form to provide its NH as
an H-bond acceptor and E271 would have to be in its
carboxylate form. Conversely, to bind ubiquinone to form
intermediate E for the reverse reaction, these residues would
have to be in the imidazole and carboxylic forms to provide
H-bond donors. If these H-bonds are essential for activation
and the pKs of the residues concerned are redox-linked to
their respective metal prosthetic groups, then the necessary
gating of binding is achieved. Specifically, if H161 is
deprotonated when the ISP is oxidized but protonated when
it is reduced, and E271 is deprotonated when heme bL is
oxidized but protonated when it is reduced, the required
conditions are met that ubiquinol only binds to FeSox/bLox
whereas ubiquinone only binds to FeSred/bLred.6. Evidence and implications
Both ISP and heme bL exhibit well-documented Em/pH
dependencies that indicate the existence of redox-linked
protonation sites. For ISP, two pKs have been found and
they have been suggested to arise from the two histidine
ligands of the 2Fe2S center [37,38]. Heme bL has multiple
weak redox-linked protonation sites [18,39] and recent
FTIR data has provided evidence for an associated redox-
linked carboxylic group [40]. However, although residues
H1621 of ISP and E271 of cytochrome b are discussed as
likely key residues here and by others, direct evidence for
protonation changes of specific residues linked to these
redox centers has yet to be obtained. FTIR spectroscopy
seems the most likely technique to provide such data in the
future.
It has not yet proved possible to crystallize the complex
with quinone(s) bound in the Qo site, although cocrystals
have been produced with a range of inhibitors. Particularly
informative are those structures with bound inhibitors that
are likely to bind with characteristics shared by binding of
ubiquinone. Perhaps the most informative of these is the
complex with bound stigmatellin [2,4]. In this case, the ring
carbonyl is H-bonded to H161 of the ISP whereas the ring
hydroxyl is H-bonded to E271 of cytochrome b. Hence,
H161 should be in its protonated state whereas E271 should
be deprotonated. In the model presented above, this would
be the case if the ISP and cytochrome b were in their
reduced and oxidized states, respectively, a thermodynam-
ically reasonable and easily accessible state because
Em(ISP)>Em(heme bL) and the one most likely for the
stigmatellin-bound complex. This structure may well pro-
vide a key insight into the reason that inhibitors such as
stigmatellin are so effective. Specifically, the inhibitor
provides an H-bond donor site and an H-bond acceptor site
at the same time, hence allowing tight binding to thethermodynamically stable ISPred/heme bLox redox confor-
mation. This configuration may also be the basis for
inhibition by quinone analogues with hydroxyl substituents
or low quinol pKs. A further corollary of this reasoning is
that, because of the relative Em values of ISP, heme bL and
ubiquinone, it is not possible to create a thermodynamically
stable mixture of redox states in which ubiquinol or ubi-
quinone can form its active complex, because this would
require ISPox/heme bLox/UQred or ISPred/heme bLred/UQox,
neither combination of which is thermodynamically stable.
Hence, this raises a novel possibility of why the Qo site is
never occupied with ubiquinone in the available crystal
structures, namely because the active enzyme–substrate
complexes can be formed only in states of kinetic disequi-
libria that exist during active respiratory electron transfer. It
could also provide a novel explanation of why inhibition of
the Qo site occurs with Qi inhibitors such as antimycin A,
since after several turnovers the system reaches the ISPox/
heme bLred state, which will have a protonation pattern at Qo
that is not conducive to effective ubiquinol binding and
activation.
Such reasoning may seem at odds with EPR data that
shows stable binding of ubiquinone to the ISPred/heme bLox
state and of ubiquinol to the fully reduced enzyme. How-
ever, it may be that these observations, based on line shape
changes of the ISP, reflect weak binding into the pocket in a
manner where only partial formation of the necessary
contacts are made, resulting in bound states that are not
sufficient for the biological bifurcation reaction. A multi-
plicity of such nonproductive states may even provide an
explanation for multiple EPR line shapes of the ISP on
titration with ubiquinone that has previously had to be
explained in terms of multiple occupancy of the Qo site
by ubiquinone [24].7. Future prospects
The model presented here draws together a number of
features and ideas that have been noted already and utilized
in models of others to explain Qo site mechanism. However,
the present model is the first to bring these together in a
manner that addresses the important concerns [18] that
require any such models to account adequately for the
known rapid reversibility of the reaction and the prevention
of side reactions that would otherwise short-circuit the
proton/electron coupling function of the enzyme. By doing
so, a viable model results that still utilizes the principles of
quinone redox chemistry in which individual steps of single
electron and proton transfer still provide the overall ‘con-
certed’ reaction mechanism, and suggests a new basis for
considerations of Qo-site occupancy and the nature of the
antimycin-inhibited state that is relevant to considerations of
the possible mechanisms of superoxide anion generation at
this site. Because the model predicts that the reactive
complex cannot be formed to significant occupancy in a
P.R. Rich / Biochimica et Biophysica Acta 1658 (2004) 165–171170static way, it does mean that it will be very difficult to access
the operative pKs, Ems and binding constants that are
relevant to catalysis. Nevertheless, some predictions are
amenable to experimental testing with methods such as IR
spectroscopy. The recent work that raises the possibility of
true concerted n= 2 chemistry [18], of long-range allosteric
effects [29,33], of intradimer (anti)cooperativity [28,32] and
of possible kinetic anomalies of cytochrome b reduction
[35] that are not the same as those explained previously by
simultaneous reactions at Qi and Qo [41] may force further
refinements but, at least for the present, the model provides
a new alternative possibility to add to those proposed
described above for further exploration of this intriguing
catalytic mechanism.Acknowledgements
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